Enhancing Antitumor Immunity with Antiangiogenic Therapy: A Clinical Model in Renal Cell Carcinoma?
Oncologist
; 24(6): 725-727, 2019 06.
Article
in En
| MEDLINE
| ID: mdl-31036769
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Carcinoma, Renal Cell
/
Antineoplastic Combined Chemotherapy Protocols
/
Angiogenesis Inhibitors
/
Antineoplastic Agents, Immunological
/
Immunotherapy
/
Kidney Neoplasms
Type of study:
Clinical_trials
/
Prognostic_studies
Limits:
Humans
Language:
En
Journal:
Oncologist
Journal subject:
NEOPLASIAS
Year:
2019
Type:
Article
Affiliation country:
United States